Atlas Capital Advisors LLC Baxter International Inc Transaction History

Atlas Capital Advisors LLC

  • $640 Billion
  • Q1 2024

A detailed history of Atlas Capital Advisors LLC transactions in Baxter International Inc stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 200 shares of BAX stock, worth $6,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Holding current value
$6,631
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
BUY
$37.88 - $43.77 $7,576 - $8,754
200 New
200 $8.55 Million
Q1 2022

May 11, 2022
SELL
$76.85 - $89.45 $537 - $626
-7 Reduced 6.54%
100 $7.75 Million
Q2 2021

Jul 30, 2021
BUY
$80.5 - $88.01 $563 - $616
7 Added 7.0%
107 $8,000
Q1 2021

May 10, 2021
SELL
$76.38 - $86.03 $214,398 - $241,486
-2,807 Reduced 96.56%
100 $8,000
Q4 2020

Feb 16, 2021
SELL
$75.39 - $82.36 $297,187 - $324,663
-3,942 Reduced 57.56%
2,907 $233,000
Q1 2020

May 04, 2020
SELL
$71.57 - $93.3 $37,717 - $49,169
-527 Reduced 7.14%
6,849 $556,000
Q3 2019

Nov 01, 2019
BUY
$81.4 - $89.78 $370,614 - $408,768
4,553 Added 161.28%
7,376 $645,000
Q2 2019

Jul 25, 2019
BUY
$73.44 - $82.41 $12,044 - $13,515
164 Added 6.17%
2,823 $0
Q1 2019

Apr 29, 2019
SELL
$64.48 - $81.31 $340,003 - $428,747
-5,273 Reduced 66.48%
2,659 $0
Q3 2018

Nov 09, 2018
BUY
$70.71 - $77.75 $372,853 - $409,975
5,273 Added 198.31%
7,932 $0
Q2 2018

Jul 30, 2018
SELL
$63.43 - $75.41 $392,631 - $466,787
-6,190 Reduced 69.95%
2,659 $0
Q1 2018

Apr 18, 2018
BUY
$62.56 - $72.26 $553,593 - $639,428
8,849 New
8,849 $0

Others Institutions Holding BAX

# of Institutions
1,025
Shares Held
442M
Call Options Held
4.22M
Put Options Held
2.52M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email